Literature DB >> 15648605

Architectural remodelling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases.

Walcy R Teodoro1, Ana P Velosa, Samira S Witzel, Ana L Garippo, Cecília Farhat, Edwin R Parra, Shigueko Sonohara, Vera L Capelozzi, Natalino H Yoshinari.   

Abstract

The pathogenesis of diffuse connective tissue diseases (DCTD) is still unknown and has been extensively studied regarding its autoimmunity aspects related to extracellular matrix (ECM) remodelling, with an emphasis on the collagens at the inflammatory site. The present paper describes the pulmonary architectural and repair/remodelling responses to injury after immunization of rabbits with human type V collagen. The animal model consisted of rabbits immunized with collagen mixed with Freund's adjuvant and sacrificed 7, 15, 30, 75, and 120 days after the first of four doses of antigen. Pulmonary architecture remodelling response was evaluated by histology, morphometry, and the immunofluorescence method, according to compartments of reference (parenchyma and interstitium) and injury: 1 inflammation (polymorphonuclear and mononuclear cells); 2-repair (fibrosis) and 3-ECM remodelling (collagen system). The results showed an intense inflammatory involvement of the pulmonary vascular and bronchiolar parenchyma, characterized by increased wall thickness in small arteries, infiltrations by pseudoeosinophils, and mononuclear cells. Progressive remodelling of the pulmonary ECM was characterized by collagen deposition in the septal and bronchovascular interstitium, especially in rabbits sacrifices at 75 and 120 days. The ECM remodelling process was not reproduced when rabbits were inoculated with collagen types I and III. We conclude that the model reproduces morphologic changes similar to those observed in many DCTD, encouraging realization of other experiments to gain a better understanding of the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648605     DOI: 10.1016/j.prp.2004.05.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia.

Authors:  Edwin Roger Parra; Walcy R Teodoro; Ana Paula Pereira Velosa; Cristiane Carla de Oliveira; Natalino Hajime Yoshinari; Vera Luiza Capelozzi
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

2.  Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior.

Authors:  Edwin Roger Parra; Leonardo Cavallari Bielecki; José Mauro da Fonseca Pestana Ribeiro; Fernando de Andrade Balsalobre; Walcy R Teodoro; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

3.  Autoantibody profile in the experimental model of scleroderma induced by type V human collagen.

Authors:  Maria R M Callado; Vilma S T Viana; Margarete B G Vendramini; Elaine P Leon; Cleonice Bueno; Ana P P Velosa; Walcy R Teodoro; Natalino H Yoshinari
Journal:  Immunology       Date:  2007-04-18       Impact factor: 7.397

4.  Unusual remodeling of the hyalinization band in vulval lichen sclerosus by type V collagen and ECM 1 protein.

Authors:  Charles A P Godoy; Walcy R Teodoro; Ana Paula P Velosa; Ana Lucia Garippo; Esmeralda Miristeni Eher; Edwin Roger Parra; Mirian N Sotto; Vera L Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2015-05-01       Impact factor: 2.365

5.  Collagen V oral administration decreases inflammation and remodeling of synovial membrane in experimental arthritis.

Authors:  Silvana Ramos Atayde; Ana Paula Pereira Velosa; Sergio Catanozi; Vanessa Del Bianco; Priscila Cristina Andrade; José Eduardo de Castro M Rodrigues; Antonio Dos Santos Filho; Leila Antonangelo; Suzana Beatriz Veríssimo de Mello; Vera Luiza Capelozzi; Walcy Rosolia Teodoro
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

6.  Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.

Authors:  Ana Paula Pereira Velosa; Lais Brito; Zelita Aparecida de Jesus Queiroz; Solange Carrasco; Jurandir Tomaz de Miranda; Cecília Farhat; Cláudia Goldenstein-Schainberg; Edwin Roger Parra; Danieli Castro Oliveira de Andrade; Pedro Leme Silva; Vera Luiza Capelozzi; Walcy Rosolia Teodoro
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

7.  Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model.

Authors:  Cristiane Carla de Oliveira; Ana Paula Pereira Velosa; Edwin Roger Parra; Vera Luiza Capelozzi; Walcy Rosolia Teodoro; Natalino Hajime Yoshinari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

8.  Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.

Authors:  Ana Paula P Velosa; Walcy R Teodoro; Daniel M dos Anjos; Renata Konno; Cristiane C Oliveira; Maria L H Katayama; Edwin R Parra; Vera L Capelozzi; Natalino H Yoshinari
Journal:  Respir Res       Date:  2010-01-04

9.  Changes in histoanatomical distribution of types I, III and V collagen promote adaptative remodeling in posterior tibial tendon rupture.

Authors:  Erika Satomi; Walcy R Teodoro; Edwin R Parra; Túlio D Fernandes; Ana Paula P Velosa; Vera Luiza Capelozzi; Natalino Hajime Yoshinari
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

10.  Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity.

Authors:  Walcy Rosolia Teodoro; Zelita Aparecida de Jesus Queiroz; Lais Araujo Dos Santos; Sergio Catanozi; Antonio Dos Santos Filho; Cleonice Bueno; Margarete B G Vendramini; Sandra de Morais Fernezlian; Esmeralda M Eher; Percival D Sampaio-Barros; Sandra Gofinet Pasoto; Fernanda Degobbi T Q S Lopes; Ana Paula Pereira Velosa; Vera Luiza Capelozzi
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.